Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolus, Inc.EOLS · Entity 5341 | Director | February 17, 2026 | February 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolus, Inc.
Report date February 17, 2026 · Filed February 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,188 |
Reported balance
After 2026-02-17 transaction · row 1
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 45,559 · Balance 134,188 F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2026 Filed Feb 20, 2026 01:57 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 45,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-26-000026 · wk-form4_1771552659.xml · nonDerivative · entry 1 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,188 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 17, 2026, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 20:28 UTC | Evolus, Inc. EOLS · Entity 5341 | PurchaseCommon Stock | 30,000 | $6.82 | $204,486.00 |
DisclosureSEC source: 0001570562-25-000102 · wk-form4_1755548897.xml · nonDerivative · entry 1 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,629 F1 · price: The shares were purchased in multiple trades at prices ranging from $6.7699 to $6.82. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:53 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 11,146 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0001570562-25-000038 · wk-form4_1741733630.xml · derivative · entry 2 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,146 Underlying: Common Stock · 11,146 shares Expires 2035-03-07 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:53 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 7,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-25-000038 · wk-form4_1741733630.xml · nonDerivative · entry 1 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,629 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of March 7, 2025, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:37 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 9,377 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001570562-24-000023 · wk-form4_1707521847.xml · derivative · entry 2 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,377 Underlying: Common Stock · 9,377 shares Expires 2034-02-07 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 23:37 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 6,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-24-000023 · wk-form4_1707521847.xml · nonDerivative · entry 1 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,265 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 7, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| January 27, 2023 Filed Feb 1, 2023 01:42 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantStock Option (Right to Buy) · Derivative | 11,789 | $0.00 Strike: $10.25 | $0.00 |
DisclosureSEC source: 0001570562-23-000026 · wf-form4_167521574831474.xml · derivative · entry 2 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,789 Underlying: Common Stock · 11,789 shares Expires 2033-01-27 F2 · derivative.exercise_date: The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer. Read SEC document |
| January 27, 2023 Filed Feb 1, 2023 01:42 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 8,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-23-000026 · wf-form4_167521574831474.xml · nonDerivative · entry 1 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,801 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:23 UTC | Evolus, Inc. EOLS · Entity 5341 | GrantCommon Stock | 36,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001570562-22-000012 · wf-form4_164159419678531.xml · nonDerivative · entry 1 Stewart Brady · CIK 0001902893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,508 F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of two years, with 1/2 of the shares subject to the option vesting annually on the anniversary of January 5, 2021, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.